2.1 min readPublished On: June 11th, 2021By News Team
GENEVA, N.Y.– Cirona Labs a premier innovator in cannabinoids and other functional botanical ingredient manufacturing, announced it has closed an oversubscribed $1.5 million seed round led by LiDestri Food & Drink, BevSource, and Sweetener Supply. The funding will be used to further expand the company’s research and development, facilities, and team as well as support a general push to market and build stronger relationships with existing brands.
“As a newly launched company we are proud to see early market traction and reach this milestone so quickly,” said Hunter Friedland, CEO of Cirona Labs. “It’s clear that the interest in creating products with cannabinoids and other plant medicine is continuing to increase and as a company focused on science and offering sustainable solutions to our customers, we are confident our high-quality products will speak for themselves in the industry.”
“LiDestri Food & Drink and Cirona Labs are both driven to innovate the food and beverage industry. And we must invest in state-of-the-art technology and cutting-edge science to bring products into the future for the best consumer experience,” said John Lidestri of LiDestri Food & Drink. “Cirona Labs will be a great partner in our company’s future progress, and we are looking forward to what’s ahead with our long-term partnership.”
“I have watched the Cirona Labs team’s growth since the early stages of the company and have been truly amazed by the drive and dedication their team has demonstrated towards creating authentic ingredients for their customers,” said Janet Johanson, CEO and Founder of BevSource. “BevSource aims to provide a seamless process for customers to build, produce and deliver the best beverage possible and Cirona Labs operates with the same goals for their partners, allowing cross-team collaboration to operate with ease.”
“The increased interest in sustainable cannabinoid use in food manufacturing is clearly evident in the current marketplace,” said Joe Gardella of Sweetener Supply. “Supporting Cirona Labs in this round of funding was an easy decision for Sweetener Supply, as they have clearly shown their product solutions are the best available for any company looking for innovation with natural ingredients.”
Cirona Labs combines powerful technology and years of expertise to create the most advanced active ingredients for infused product makers. Passionate about true scientific innovation, the company provides consistent and efficacious products to consumers while helping manufacturers streamline processes.
(This information is primarily sourced from Cirona Labs. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Pharmaceuticals Inc. announced today the peer-reviewed publication of its sponsored preclinical study titled "The Effect of Isolated Cannabinoid Extracts on Polypoid Colorectal Tissue" in the International Journal of Molecular Sciences; concluding "possible future therapeutic value" for the ...
LAS VEGAS, Sept. 29, 2022 Hippo Premium Packaging a provider of custom packaging and branding solutions to the cannabis and hemp industries, specializes in designing beautiful custom packaging for the cannabis and hemp industries. The ...
LANSING, Mich., Sept. 28, 2022 ACT Laboratories, Inc. a testing company in the legal cannabis and hemp markets, today announced an agreement to acquire CDX Analytics, LLC ("CDX") of Massachusetts "ACT Labs is out to build the foremost, ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more